MAY 04, 2015 10:51 PM PDT

Biomarker in Blood Test May Have Early Cancer Answer

A distinct pattern in a blood test could predict cancer years before an actual diagnosis, according to a new study by Northwestern University researchers published in the journal, EBioMedicine. The National Institutes of Health funded the study.
A blood test may indicate the development of cancer years before it actually happens.
The researchers working with lead author Lifang Hou, professor of preventive medicine at Northwestern University Feinberg School of Medicine, and Andrea Baccarelli, from Harvard University, the study's senior author, described a pattern of rapid shortening of blood telomeres followed by stabilization three or four years before the diagnosis of cancer. This scenario could lead to a new biomarker that would predict the development of cancer using a blood test.

The study represents the first reported trajectory of changes in telomeres - the end caps on DNA strands that protect the chromosomes - over the years in people developing cancer. Some people liken telomeres to the plastic tips at the end of shoelaces that keep them from becoming frayed.

According to www.tasciences.com/what-is-a-telomere/, telomeres are an essential part of human cells that affect how cells age. Telomere (tel-uh-meer) comes from the Greek telos (end) and meros (part). Without telomeres, DNA strands become damaged, and cells are unable to do their job.

Researchers have attempted to understand how blood cell telomeres were affected in people developing cancer. In previous studies results have shown telomeres to be shorter, longer or not affected at all. The new study showed the reasons for inconsistency.

In obtaining multiple measurements of telomeres over a 13-year period in 792 people, 135 of whom were eventually diagnosed with different types of cancer, the scientists initially discovered that telomeres aged much faster in people who were developing but not yet diagnosed with cancer. It appeared that telomeres in people developing cancer were as much as 15 years chronologically older than those of people who were not developing the disease, but then the scientists discovered that the accelerated aging process stopped three to four years before the cancer diagnosis.

According to Hou, "Understanding this pattern of telomere growth may mean it can be a predictive biomarker for cancer. Because we saw a strong relationship in the pattern across a wide variety of cancers, with the right testing these procedures could be used to eventually diagnose a wide variety of cancers."

He added, "This likely explains why the previous studies have been so inconsistent. We saw the inflection point at which rapid telomere shortening stabilizes. We found cancer has hijacked the telomere shortening in order to flourish in the body."

This is the first time a study had looked at telomere length at more than one time point before diagnosis. Cancer treatment can shorten telomeres, after which it is uncertain whether the cancer or the treatment has affected their length.

Every time a cell divides, telomeres get shorter. The older a person is, the more times each cell in his or her body has divided and the shorter the telomeres. Cancer cells divide and grow rapidly, making scientists think that the cell would get short enough to self-destruct. However, scientists found that cancer finds a way to stop that process.

When scientists learn how cancer attacks the cell, they may be able to develop treatments that cause cancer cells to self-destruct without harming healthy cells, Hou concluded.

Source: Northwestern University

The post "Can this blood test predict cancer years early?" appeared first on "Futurity."
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
JUN 19, 2018
Earth & The Environment
JUN 19, 2018
Does Roundup cause cancer?
Monsanto has long been the scary monster lurking in the closet, with its seed-patenting and fertilizer-pushing. Now the first case actually bringing the co...
AUG 13, 2018
Videos
AUG 13, 2018
What does sunscreen look like with a UV camera?
  Have you ever wondered if there’s really a difference between SPF 30 and SPF 50? You’re not the only one. YouTuber Physics Girl set out...
AUG 21, 2018
Cancer
AUG 21, 2018
'Zombie' gene returns to life and kills cancer in elephants
Researchers have discovered a gene that can protect elephants from cancer. An estimated 17 percent of humans worldwide die from cancer, but less than five ...
SEP 02, 2018
Cell & Molecular Biology
SEP 02, 2018
Cancer Cell Lines can Evolve in the Lab
New research shows that scientists have to take steps to verify the identity of the cell lines they grow....
SEP 26, 2018
Videos
SEP 26, 2018
Cancer Immunotherapy
Video illustration about how tumor cells are sensed and destroyed by the immune system and how tumors evolve and detect immune-mediated eliminations, as well as iimmunotherapies associated....
OCT 06, 2018
Drug Discovery
OCT 06, 2018
New Class of Drugs for Breast Cancer Therapy
Scientists at Stevens Institute of Technology have designed a new class of molecules that may hold the potential to add to the arsenal of drugs actively be...
Loading Comments...